Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Article
  • Published:

Polymorphisms in CEP68 gene associated with risk of immediate selective reactions to non-steroidal anti-inflammatory drugs

Abstract

Non-steroidal anti-inflammatory drugs (NSAIDs) are the main triggers of drug hypersensitivity reactions. Such reactions can be pharmacologically or immunologically mediated, but in both cases individual susceptibility can be influenced by genetic factors. Polymorphisms in centrosomal protein of 68 kDa (CEP68) have been associated with pharmacologically mediated NSAIDs reactions. Here, we evaluated this gene in immunologically mediated single-NSAID-induced urticaria/angioedema or anaphylaxis (SNIUAA) by analyzing 52 single nucleotide polymorphisms in CEP68 in 176 patients and 363 NSAIDs-tolerant controls. Two intronic variants (rs2241160 and rs2241161) were significantly associated with an increased risk of SNIUAA, suggesting CEP68 to be a key player in both types of NSAIDs hypersensitivity. However, we found no overlap with genetic variants previously associated with pharmacologically mediated hypersensitivity, pointing to a complex role for this gene and its potential use in the development of biomarkers of clinical utility to diagnose patients at risk of these reactions and to differentiate entities.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Fig. 1

Similar content being viewed by others

References

  1. Conaghan PG. A turbulent decade for NSAIDs: update on current concepts of classification, epidemiology, comparative efficacy, and toxicity. Rheumatol Int. 2012;32:1491–502.

    Article  CAS  PubMed  Google Scholar 

  2. Wertli MM, Reich O, Signorell A, Burgstaller JM, Steurer J, Held U. Changes over time in prescription practices of pain medications in Switzerland between 2006 and 2013: an analysis of insurance claims. BMC Health Serv Res. 2017;17:167.

    Article  PubMed  PubMed Central  Google Scholar 

  3. Doña I, Blanca-Lopez N, Torres MJ, Garcia-Campos J, Garcia-Nuñez I, Gomez F, et al. Drug hypersensitivity reactions: response patterns, drug involved, and temporal variations in a large series of patients. J Investig Allergol Clin Immunol. 2012;22:363–71.

    PubMed  Google Scholar 

  4. Cornejo-Garcia JA, Blanca-Lopez N, Doña I, Andreu I, Agundez JA, Carballo M, et al. Hypersensitivity reactions to non-steroidal anti-inflammatory drugs. Curr Drug Metab. 2009;10:971–80.

    Article  CAS  PubMed  Google Scholar 

  5. Faria E, Rodrigues-Cernadas J, Gaspar A, Botelho C, Castro E, Lopes A, et al. Drug-induced anaphylaxis survey in Portuguese Allergy Departments. J Investig Allergol Clin Immunol. 2014;24:40–48.

    CAS  PubMed  Google Scholar 

  6. Aun MV, Blanca M, Garro LS, Ribeiro MR, Kalil J, Motta AA, et al. Nonsteroidal anti-inflammatory drugs are major causes of drug-induced anaphylaxis. J Allergy Clin Immunol Pract. 2014;2:414–20.

    Article  PubMed  Google Scholar 

  7. Ensina LF, de Lacerda AE, de Andrade DM, Machado L, Camelo-Nunes I, Sole D. Drug-induced anaphylaxis in children: nonsteroidal anti-inflammatory drugs and drug provocation test. J Allergy Clin Immunol Pract. 2014;2:825.

    Article  PubMed  Google Scholar 

  8. Kowalski ML, Asero R, Bavbek S, Blanca M, Blanca-Lopez N, Bochenek G, et al. Classification and practical approach to the diagnosis and management of hypersensitivity to nonsteroidal anti-inflammatory drugs. Allergy. 2013;68:1219–32.

    Article  CAS  PubMed  Google Scholar 

  9. Doña I, Blanca-Lopez N, Cornejo-Garcia JA, Torres MJ, Laguna JJ, Fernandez J, et al. Characteristics of subjects experiencing hypersensitivity to non-steroidal anti-inflammatory drugs: patterns of response. Clin Exp Allergy. 2011;41:86–95.

    Article  PubMed  Google Scholar 

  10. Demir S, Olgac M, Unal D, Gelincik A, Colakoglu B, Buyukozturk S. Evaluation of hypersensitivity reactions to nonsteroidal anti-inflammatory drugs according to the latest classification. Allergy. 2015;70:1461–7.

    Article  CAS  PubMed  Google Scholar 

  11. Himly M, Jahn-Schmid B, Pittertschatscher K, Bohle B, Grubmayr K, Ferreira F, et al. IgE-mediated immediate-type hypersensitivity to the pyrazolone drug propyphenazone. J Allergy Clin Immunol. 2003;111:882–8.

    Article  CAS  PubMed  Google Scholar 

  12. Harrer A, Lang R, Grims R, Braitsch M, Hawranek T, Aberer W, et al. Diclofenac hypersensitivity: antibody responses to the parent drug and relevant metabolites. PLoS One. 2010;5:e13707.

    Article  PubMed  PubMed Central  Google Scholar 

  13. Kay E, Ben-Shoshan M Anaphylaxis to ibuprofen in a 12-year-old boy. BMJ Case Rep. 2013;1–3 2013.

  14. Couto M, Gaspar A, Morais-Almeida M. Selective anaphylaxis to paracetamol in a child. Eur Ann Allergy Clin Immunol. 2012;44:163–6.

    CAS  PubMed  Google Scholar 

  15. Cornejo-Garcia JA, Jurado-Escobar R, Doña I, Perkins JR, Agundez JA, Garcia-Martin E, et al. The genetics of drug hypersensitivity reactions. J Investig Allergol Clin Immunol. 2016;26:222–32. quiz next two pages

    Article  CAS  PubMed  Google Scholar 

  16. Jurado-Escobar R, Perkins JR, Garcia-Martin E, Isidoro-Garcia M, Doña I, Torres MJ, et al. Update on the genetic basis of drug hypersensitivity reactions. J Investig Allergol Clin Immunol. 2017;27:336–45.

    Article  CAS  PubMed  Google Scholar 

  17. Kim JH, Park BL, Cheong HS, Bae JS, Park JS, Jang AS, et al. Genome-wide and follow-up studies identify CEP68 gene variants associated with risk of aspirin-intolerant asthma. PLoS One. 2010;5:e13818.

    Article  PubMed  PubMed Central  Google Scholar 

  18. Cornejo-Garcia JA, Flores C, Plaza-Seron MC, Acosta-Herrera M, Blanca-Lopez N, Doña I, et al. Variants of CEP68 gene are associated with acute urticaria/angioedema induced by multiple non-steroidal anti-inflammatory drugs. PLoS One. 2014;9:e90966.

    Article  PubMed  PubMed Central  Google Scholar 

  19. Amo G, Cornejo-Garcia JA, Garcia-Menaya JM, Cordobes C, Torres MJ, Esguevillas G, et al. FCERI and histamine metabolism gene variability in selective responders to NSAIDS. Front Pharmacol. 2016;7:353.

    Article  PubMed  PubMed Central  Google Scholar 

  20. Blanca-Lopez N, Perez-Sanchez N, Agundez JA, Garcia-Martin E, Torres MJ, Cornejo-Garcia JA, et al. Allergic reactions to metamizole: immediate and delayed responses. Int Arch Allergy Immunol. 2016;169:223–30.

    Article  CAS  PubMed  Google Scholar 

  21. Ortega N, Doña I, Moreno E, Audicana MT, Barasona MJ, Berges-Gimeno MP, et al. Practical guidelines for diagnosing hypersensitivity reactions to nonsteroidal anti-inflammatory drugs. J Investig Allergol Clin Immunol. 2014;24:308–23.

    CAS  PubMed  Google Scholar 

  22. Weale ME, Depondt C, Macdonald SJ, Smith A, Lai PS, Shorvon SD, et al. Selection and evaluation of tagging SNPs in the neuronal-sodium-channel gene SCN1A: implications for linkage-disequilibrium gene mapping. Am J Hum Genet. 2003;73:551–65.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  23. Pruim RJ, Welch RP, Sanna S, Teslovich TM, Chines PS, Gliedt TP, et al. LocusZoom: regional visualization of genome-wide association scan results. Bioinformatics. 2010;26:2336–7.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  24. Xu Z, Taylor JA. SNPinfo: integrating GWAS and candidate gene information into functional SNP selection for genetic association studies. Nucleic Acids Res. 2009;37(Web Server issue):W600–605.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  25. Yuan HY, Chiou JJ, Tseng WH, Liu CH, Liu CK, Lin YJ, et al. FASTSNP: an always up-to-date and extendable service for SNP function analysis and prioritization. Nucleic Acids Res. 2006;34(Web Server issue):W635–641.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  26. Wigginton JE, Cutler DJ, Abecasis GR. A note on exact tests of Hardy-Weinberg equilibrium. Am J Hum Genet. 2005;76:887–93.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  27. Pino-Yanes M, Corrales A, Basaldua S, Hernandez A, Guerra L, Villar J, et al. North African influences and potential bias in case-control association studies in the Spanish population. PLoS One. 2011;6:e18389.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  28. Li Y, Willer CJ, Ding J, Scheet P, Abecasis GR. MaCH: using sequence and genotype data to estimate haplotypes and unobserved genotypes. Genet Epidemiol. 2010;34:816–34.

    Article  PubMed  PubMed Central  Google Scholar 

  29. Genomes Project C, Abecasis GR, Auton A, Brooks LD, DePristo MA, Durbin RM, et al. An integrated map of genetic variation from 1,092 human genomes. Nature. 2012;491:56–65.

    Article  Google Scholar 

  30. Garcia-Closas M, Lubin JH. Power and sample size calculations in case-control studies of gene-environment interactions: comments on different approaches. Am J Epidemiol. 1999;149:689–92.

    Article  CAS  PubMed  Google Scholar 

  31. Asero R. Single NSAID hypersensitivity is associated with atopic status. Eur Ann Allergy Clin Immunol. 2015;47:48–53.

    CAS  PubMed  Google Scholar 

  32. Consortium EP. An integrated encyclopedia of DNA elements in the human genome. Nature. 2012;489:57–74.

    Article  Google Scholar 

  33. Hirose T, Steitz JA. Position within the host intron is critical for efficient processing of box C/D snoRNAs in mammalian cells. Proc Natl Acad Sci USA. 2001;98:12914–9.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  34. Kim YK, Kim VN. Processing of intronic microRNAs. EMBO J. 2007;26:775–83.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  35. Alekseyenko AV, Kim N, Lee CJ. Global analysis of exon creation versus loss and the role of alternative splicing in 17 vertebrate genomes. RNA. 2007;13:661–70.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  36. Burgner D, Davila S, Breunis WB, Ng SB, Li Y, Bonnard C, et al. A genome-wide association study identifies novel and functionally related susceptibility Loci for Kawasaki disease. PLoS Genet. 2009;5:e1000319.

    Article  PubMed  PubMed Central  Google Scholar 

  37. Low SK, Takahashi A, Ebana Y, Ozaki K, Christophersen IE, Ellinor PT, et al. Identification of six new genetic loci associated with atrial fibrillation in the Japanese population. Nat Genet. 2017;49:953–8.

    Article  CAS  PubMed  Google Scholar 

  38. Kumar A, Shetty J, Kumar B, Blanton SH. Confirmation of linkage and refinement of the RP28 locus for autosomal recessive retinitis pigmentosa on chromosome 2p14-p15 in an Indian family. Mol Vis. 2004;10:399–402.

    PubMed  Google Scholar 

  39. Kang X, Liu H, Onaitis MW, Liu Z, Owzar K, Han Y, et al. Polymorphisms of the centrosomal gene (FGFR1OP) and lung cancer risk: a meta-analysis of 14,463 cases and 44,188 controls. Carcinogenesis. 2016;37:280–9.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  40. Hussain MS, Baig SM, Neumann S, Nurnberg G, Farooq M, Ahmad I, et al. A truncating mutation of CEP135 causes primary microcephaly and disturbed centrosomal function. Am J Hum Genet. 2012;90:871–8.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  41. Lee JE, Silhavy JL, Zaki MS, Schroth J, Bielas SL, Marsh SE, et al. CEP41 is mutated in Joubert syndrome and is required for tubulin glutamylation at the cilium. Nat Genet. 2012;44:193–9.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  42. Kumar A, Purohit R. Computational investigation of pathogenic nsSNPs in CEP63 protein. Gene. 2012;503:75–82.

    Article  CAS  PubMed  Google Scholar 

  43. Maheshwari R, Dhathathreyan A. Investigation of surface properties of amino acids: polarity scale for amino acids as a means to predict surface exposed residues in films of proteins. J Colloid Interface Sci. 2004;277:79–83.

    Article  CAS  PubMed  Google Scholar 

  44. Andersen JS, Wilkinson CJ, Mayor T, Mortensen P, Nigg EA, Mann M. Proteomic characterization of the human centrosome by protein correlation profiling. Nature. 2003;426:570–4.

    Article  CAS  PubMed  Google Scholar 

  45. Graser S, Stierhof YD, Nigg EA. Cep68 and Cep215 (Cdk5rap2) are required for centrosome cohesion. J Cell Sci. 2007;120(Pt 24):4321–31.

    Article  CAS  PubMed  Google Scholar 

  46. Chen Y, Low TY, Choong LY, Ray RS, Tan YL, Toy W, et al. Phosphoproteomics identified Endofin, DCBLD2, and KIAA0582 as novel tyrosine phosphorylation targets of EGF signaling and Iressa in human cancer cells. Proteomics. 2007;7:2384–97.

    Article  CAS  PubMed  Google Scholar 

  47. Kim Y, Kim K, Park D, Eom S, Park H, Lee H, et al. Integrin alpha(5) interacts with EGFR, is necessary for FcvarepsilonRI signaling and is necessary for allergic inflammation in relation with angiogenesis. Mol Immunol. 2011;48:1035–45.

    Article  CAS  PubMed  Google Scholar 

  48. Hirota N, Risse PA, Novali M, McGovern T, Al-Alwan L, McCuaig S, et al. Histamine may induce airway remodeling through release of epidermal growth factor receptor ligands from bronchial epithelial cells. FASEB J. 2012;26:1704–16.

    Article  CAS  PubMed  Google Scholar 

  49. McGovern T, Risse PA, Tsuchiya K, Hassan M, Frigola G, Martin JG. LTD(4) induces HB-EGF-dependent CXCL8 release through EGFR activation in human bronchial epithelial cells. Am J Physiol Lung Cell Mol Physiol. 2010;299:L808–815.

    Article  CAS  PubMed  Google Scholar 

  50. Holowka D, Wilkes M, Stefan C, Baird B. Roles for Ca2+ mobilization and its regulation in mast cell functions: recent progress. Biochem Soc Trans. 2016;44:505–9.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

Download references

Acknowledgements

This work was supported by grants co-funded by the European Regional Development Fund (ERDF), from the Carlos III National Health Institute (ARADyAL network RD16/0006/0001, RD16/0006/004, RD16/0006/0007, RD16/0006/0019, PI15/00303, and PI17/01593), and the Health Government of Andalusia (PI-0463-2013), and Junta de Extremadura (IB16170). JA Cornejo-García is a researcher from the Miguel Servet Program (Ref CP14/00034), JR Perkins from the Sara Borrell Program (Ref CD14/00242), and I Doña from the Juan Rodés Program (Ref JR15/0036both from the Carlos III National Health Institute, Spanish Ministry of Economy and Competitiveness). M Acosta-Herrera is recipient of a Juan de la Cierva fellowship (FJCI-2015-24028) from the Spanish Ministry of Economy, Industry and Competitiveness. We thank the Malaga Hospital-IBIMA Biobank, belonging to the Andalusian Public Health System Biobank and the National Biobank Platform (project PT13/ 0010/0006, PT13/0010/0033), for sample management, and Dr. Juan Miguel Gómez Zumaquero from the Genomic Unit of IBIMA for his help with genotyping.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to José A. Cornejo-García.

Ethics declarations

Conflict of interest

The authors declare that they have no conflict of interest.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Perkins, J.R., Acosta-Herrera, M., Plaza-Serón, M.C. et al. Polymorphisms in CEP68 gene associated with risk of immediate selective reactions to non-steroidal anti-inflammatory drugs. Pharmacogenomics J 19, 191–199 (2019). https://doi.org/10.1038/s41397-018-0038-0

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/s41397-018-0038-0

This article is cited by

Search

Quick links